Understanding Numbness and Other Effects of the DermalMarket Double Chin Reducer
The DermalMarket Double Chin Reducer Side Effects include temporary numbness in 23–37% of users, according to clinical trials and post-market surveillance. This sensation typically lasts 15–90 minutes post-application and resolves without intervention. Let’s unpack why this happens, how it compares to alternatives, and what science says about its safety.
Why Does Numbness Occur?
The device uses low-temperature cryolipolysis (fat freezing) combined with microcurrent technology. Here’s the breakdown:
Key Mechanism:
- Cryolipolysis: Cools subcutaneous fat to -11°C (12.2°F), temporarily numbing nerve endings
- Microcurrents: Delivers 200–400 µA pulses to stimulate muscle toning
A 2023 study in the Journal of Cosmetic Dermatology showed 68% of participants experienced numbness during the first three sessions, dropping to 12% by week 4 as nerves adapted.
Side Effect Frequency and Duration
Data from 1,200 users (DermalMarket’s 2024 safety report):
| Side Effect | Frequency | Average Duration | Severity |
|---|---|---|---|
| Numbness | 34% | 47 minutes | Mild |
| Redness | 28% | 25 minutes | Moderate |
| Tingling | 19% | 33 minutes | Mild |
| Swelling | 8% | 2.1 hours | Moderate |
Critical note: Only 0.3% required medical attention (primarily due to pre-existing neurological conditions).
Comparative Safety Profile
How it stacks up against other chin fat reduction methods:
- Kybella®: 62% bruising rate vs. DermalMarket’s 11%
- CoolSculpting: 15% risk of paradoxical adipose hyperplasia (vs. 0% here)
- Liposuction: 3–5% infection risk vs. non-invasive alternatives
A 6-month University of Michigan study found 89% of DermalMarket users preferred it over injectables due to fewer systemic effects.
Managing and Preventing Numbness
Evidence-based strategies from dermatologists:
- Pre-cool the skin with the included gel pack (reduces numbness duration by 41%)
- Use intensity levels 1–3 during initial weeks (avoids overstimulation)
- Massage the area post-treatment (increases blood flow by 27%)
Users who followed the protocol saw a 63% faster resolution of numbness compared to those who didn’t.
Long-Term Safety Data
Follow-up studies at 12 months show:
- No permanent nerve damage in 1,448 participants
- Fat reduction maintained in 82% of cases
- 83% reduction in side effect frequency after 8 weeks
The device meets FDA’s non-significant risk (NSR) criteria, with a 0.02% discontinuation rate due to discomfort.
When to Be Concerned
Seek medical advice if numbness:
- Persists beyond 4 hours
- Accompanies muscle weakness
- Occurs with vision changes (rare but possible with improper use)
The American Society for Dermatologic Surgery recommends spacing treatments 72 hours apart to allow nerve recovery.
User Experience Trends
Analysis of 947 verified reviews shows:
- 74% reported numbness decreased after 5–7 uses
- 91% considered effects “manageable” compared to results
- Only 6% discontinued use – primarily due to sensitivity rather than safety
This aligns with the device’s 4.2/5 satisfaction rating across clinical trial sites.
The Bottom Line
While numbness is common with the DermalMarket Double Chin Reducer, it’s generally transient and mild. Clinical data confirms its safety profile surpasses many alternatives, particularly for those seeking non-invasive solutions. Proper technique and gradual intensity progression remain critical to minimizing temporary sensory effects.